Literature DB >> 11683650

Redundancy of mammalian proteasome beta subunit function during endoplasmic reticulum associated degradation.

J Oberdorf1, E J Carlson, W R Skach.   

Abstract

Misfolded proteins in the endoplasmic reticulum (ER) are degraded by N-terminal threonine proteases within the 26S proteasome. Each protease is formed by an activated beta subunit, beta5/X, beta1/Y, or beta2/Z, that exhibits chymotrypsin-like, peptidylglutamyl-peptide hydrolyzing, or trypsin-like activity, respectively. Little is known about the relative contribution of specific beta subunits in the degradation of endogenous protein substrates. Using active site proteasome inhibitors and a reconstituted degradation system, we now show that all three active beta subunits can independently contribute to ER-associated degradation of the cystic fibrosis transmembrane conductance regulator (CFTR). Complete inactivation (>99.5%) of the beta5/X subunit decreased the rate of ATP-dependent conversion of CFTR to trichloroacetic acid soluble fragments by only 40%. Similarly, proteasomes containing only active beta1/Y or beta2/Z subunits degraded CFTR at approximately 50% of the rate observed for fully functional proteasomes. Simultaneous inhibition (>93%) of all three beta subunits blocked CFTR degradation by approximately 90%, and inhibition of both protease and ATPase activities was required to completely prevent generation of small peptide fragments. Our results demonstrate both a conserved hierarchy (ChT-L > PGPH > or = T-L) as well as a redundancy of beta subunit function and provide insight into the mechanism by which active site proteasome inhibitors influence degradation of endogenous protein substrates at the ER membrane.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683650     DOI: 10.1021/bi011322y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  p97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation.

Authors:  Eric J Carlson; David Pitonzo; William R Skach
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

2.  Global organization and function of mammalian cytosolic proteasome pools: Implications for PA28 and 19S regulatory complexes.

Authors:  Toru Shibatani; Eric J Carlson; Fredrick Larabee; Ashley L McCormack; Klaus Früh; William R Skach
Journal:  Mol Biol Cell       Date:  2006-09-20       Impact factor: 4.138

3.  Inhibition of proteasome activity impairs centrosome-dependent microtubule nucleation and organization.

Authors:  Christine Didier; Andreas Merdes; Jean-Edouard Gairin; Nabila Jabrane-Ferrat
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

4.  Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites.

Authors:  Matthew Britton; Marcella M Lucas; Sondra L Downey; Michael Screen; Alexandre A Pletnev; Martijn Verdoes; Robert A Tokhunts; Omar Amir; Ayrton L Goddard; Philip M Pelphrey; Dennis L Wright; Herman S Overkleeft; Alexei F Kisselev
Journal:  Chem Biol       Date:  2009-12-24

5.  Substrate-guided optimization of the syringolins yields potent proteasome inhibitors with activity against leukemia cell lines.

Authors:  Kyle A Totaro; Dominik Barthelme; Peter T Simpson; Robert T Sauer; Jason K Sello
Journal:  Bioorg Med Chem       Date:  2015-07-26       Impact factor: 3.641

6.  Molecular characterization, expression analysis and association study with immune traits of porcine PSMB6 gene.

Authors:  Xiao Wu; Yanfang Wang; Yunzi Sun
Journal:  Mol Biol Rep       Date:  2011-05-22       Impact factor: 2.316

7.  The activation of the chymotrypsin-like activity of the proteasome is regulated by soluble adenyl cyclase/cAMP/protein kinase A pathway and required for human sperm capacitation.

Authors:  Héctor Zapata-Carmona; Lina Barón; Lidia M Zuñiga; Emilce Silvina Díaz; Milene Kong; Erma Z Drobnis; Peter Sutovsky; Patricio Morales
Journal:  Mol Hum Reprod       Date:  2019-10-28       Impact factor: 4.025

8.  Regulation of the neuronal proteasome by Zif268 (Egr1).

Authors:  Allan B James; Ann-Marie Conway; Brian J Morris
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

Review 9.  Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy.

Authors:  Michael Basler; Marcus Groettrup
Journal:  Genes Immun       Date:  2020-08-25       Impact factor: 2.676

10.  ADD66, a gene involved in the endoplasmic reticulum-associated degradation of alpha-1-antitrypsin-Z in yeast, facilitates proteasome activity and assembly.

Authors:  Craig M Scott; Kristina B Kruse; Béla Z Schmidt; David H Perlmutter; Ardythe A McCracken; Jeffrey L Brodsky
Journal:  Mol Biol Cell       Date:  2007-07-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.